Baclofen

Thông số

1134-47-0Số CAS

214-486-9Số EC

4-amino-3-(4-chlorophenyl)butanoic acidTên IUPAC

C10H12ClNO2Công thức hóa học

213.66 g/molKhối lượng phân tử

baclofen; 1134-47-0; Lioresal; 4-Amino-3-(4-chlorophenyl)butanoic acid; Baclon; Kemstro; DL-Baclofen; Baclofene; Baclofeno; (+-)-Baclofen; 4-Amino-3-(4-chlorophenyl)butyric acid; Baclofenum; Baclophen; beta-(4-Chlorophenyl)gaba; Lioresal Intrathecal; (RS)-BACLOFEN; Ba-34647; Gablofen; Ciba 34,647-Ba; beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; Ba-34,647; DL-4-Amino-3-p-chlorophenylbutanoic acid; C 34647Ba; beta-(p-Chlorophenyl)-gamma-aminobutyric acid; Ba 34647; DTXSID5022641; beta-(Aminomethyl)-p-chlorohydrocinnamic acid; gamma-Amino-beta-(p-chlorophenyl)butyric acid; FLEQSUVY; LYVISPAH; Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-; NSC-755906; OZOBAX; H789N3FKE8; CHEBI:2972; DTXCID002641; Chlorophenyl GABA; NSC329137; HYDROCINNAMIC ACID, beta-(AMINOMETHYL)-p-CHLORO-; Genpharm; ApoBaclofen; GenBaclofen; NuBaclo; Apo Baclofen; Gen Baclofen; PCP-GABA; PMSBaclofen; Nu Baclo; PMS Baclofen; AWD, Baclofen; GABA, Chlorophenyl; CIBA-34,647-BA; CIBA34,647BA; Ba34647; Ba34,647; M03BX01; Lyflex; Lioresal intrath; Baclofen Injection; Baclospas-10; Lioresal (baclofen); OZOBAX DS; Baclofen (Intrathecal); RefChem:5578; 4-amino-3-(4-chlorophenyl)-butanoic acid; (3RS)-4-Amino-3-(4-chlorophenyl)butanoic acid; 214-486-9; Gabalon; (+/-)-BACLOFEN; Baclofen (R,S); Butanoic acid, 4-amino-3-(4-chlorophenyl)-; MFCD00055143; CHEMBL701; Atrofen; Apo-Baclofen; ( inverted exclamation markA)-BACLOFEN; NCGC00015156-11; (RS)-Amino-3-(4-chlorophenyl)butyric acid; M01382; Baclofene [INN-French]; Baclofenum [INN-Latin]; .beta.-(Aminomethyl)-p-chlorohydrocinnamic acid; Baclofeno [INN-Spanish]; .beta.-(Aminomethyl)-4-chlorobenzenepropanoic acid; MFCD01321057; Lioresal (TN); Kemstro (TN); CCRIS 3722; SR-01000000107; EINECS 214-486-9; (+)-Baclofen; (L)-Baclofen; BRN 2104494; Baclofen; (3RS)-4-Amino-3-(4-chlorophenyl)butanoic acid; UNII-H789N3FKE8; baclofen o; IPX056; Baclofen CRS; IPX 056; (y)-Baclofen; Prestwick_85; CAS-1134-47-0; (?)-Baclofen; (R,S)-Baclofen; Baclofen (Standard); Baclofen [USAN:USP:INN:BAN:JAN]; (A+/-)-Baclofen; Spectrum_000066; BACLOFEN [USAN]; BACLOFEN [INN]; BACLOFEN [JAN]; BACLOFEN [MI]; BACLOFEN [VANDF]; (.+/-.)-Baclofen; (.+/-.)-Baklofen; Prestwick0_000085; Prestwick1_000085; Prestwick2_000085; Prestwick3_000085; Spectrum2_000092; Spectrum3_000310; Spectrum4_000245; Spectrum5_000852; BACLOFEN [MART.]; BACLOFEN [USP-RS]; BACLOFEN [WHO-DD]; Biomol-NT_000251; UPCMLD-DP142; B 5399; b-(4-Chlorophenyl)-GABA; Lopac0_000163; Oprea1_440627; SCHEMBL19333; BSPBio_000010; BSPBio_001880; KBioGR_000650; KBioSS_000466; Baclofen - Bio-X trade mark; MLS000028480; .beta.-(4-Chlorophenyl)gaba; DivK1c_000001; SPECTRUM1500135; Baclofen (JP18/USP/INN); Hydrocinnamic acid, .beta.-(aminomethyl)-p-chloro-; SPBio_000044; SPBio_001949; BACLOFEN [ORANGE BOOK]; Benzenepropanoic acid, .beta.-(aminomethyl)-4-chloro-; BPBio1_000012; BPBio1_000750; GTPL1084; orb1226943; orb1309888; orb3139324; BACLOFEN [EP MONOGRAPH]; (+/-)-beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; BACLOFEN [USP MONOGRAPH]; UPCMLD-DP142:001; BDBM24182; HMS500A03; HY-B0007R; KBio1_000001; KBio2_000466; KBio2_003034; KBio2_005602; KBio3_001380; Baclofen 0.5 mg/ml in Methanol; NINDS_000001; GLXC-06867; HMS1568A12; HMS1920E21; HMS2091M03; HMS2095A12; HMS3260B07; HMS3712A12; Pharmakon1600-01500135; ( inverted question mark)-Baclofen; ALBB-014712; EX-A1378; HY-B0007; MSK10343; Tox21_110090; Tox21_500163; BBL010735; CCG-38910; CX1358; EBC-26219; HB0953; NSC755906; s3072; s4840; STK535284; AKOS005174692; Tox21_110090_1; AC-4530; DB00181; FB18127; HS-1001; LP00163; MB00475; NSC 755906; NSC-329137; SB67382; SDCCGSBI-0050151.P005; 4-Amino-3-(4-chlorophenyl)butanoicacid; 4-Amino-3-(p-chlorophenyl)butyric acid; IDI1_000001; SMP1_000036; NCGC00015156-04; NCGC00015156-05; NCGC00015156-06; NCGC00015156-07; NCGC00015156-08; NCGC00015156-12; NCGC00015156-13; NCGC00015156-15; NCGC00015156-26; NCGC00015156-28; NCGC00023843-03; NCGC00024579-03; NCGC00024579-04; NCGC00024579-05; NCGC00024579-06; NCGC00260848-01; BB166152; SMR000058294; ST075584; SY023865; SY052300; b-(Aminomethyl)-p-chlorohydrocinnamic acid; SBI-0050151.P004; (+/-)-Baclofen, >=98% (TLC), solid; 4-Amino-3-(4-chlorophenyl)butanoic acid #; AB00051921; B0110; B3343; EU-0100163; NS00007882; b-(Aminomethyl)-4-chloro-benzenepropanoic acid; Baclofen, 1mg/ml in Acetonitrile/Water : 1/1; D00241; EN300-118715; (RS)-4-Amino-3-(4-chlorophenyl)buta noic acid; AB00051921_16; .beta.-(p-Chlorophenyl)-.gamma.-aminobutyric acid; .gamma.-Amino-.beta.-(p-chlorophenyl)butyric acid; 4-Amino-3-(4-chlorophenyl)butyric Acid, Baclofen; L000002; Q413717; SR-01000000107-2; SR-01000000107-4; SR-01000000107-6; SR-01000000107-8; (+/-)-ss-(Aminomethyl)-4-chlorobenzenepropanoic acid; BRD-A84174873-001-05-2; BRD-A84174873-003-07-4; (+/- )-beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; Baclofen, British Pharmacopoeia (BP) Reference Standard; Baclofen, European Pharmacopoeia (EP) Reference Standard; F2173-1127; Baclofen Lioresal 4-Amino-3-(4-chlorophenyl)butyric acid; Baclofen, United States Pharmacopeia (USP) Reference Standard; Baclofen, Pharmaceutical Secondary Standard; Certified Reference MaterialTên gọi khác